Helen O'Neill
@drhelenoneill
Associate Professor in Reproductive and Molecular Genetics @UCL working on #CRISPR genome editing. CEO and Founder @Hertilityhealth
ID: 3311742983
07-06-2015 10:40:57
734 Tweet
3,3K Followers
3,3K Following
1 in 6 people globally affected by infertility says the WHO. "The most prevalent reason why we are suffering from infertility is simply that we are waiting too late for children." Helen O'Neill discusses infertility issues 👇 trib.al/Rx0iR33 📺 Sky 501 and YouTube
Throwback to our #LondonTechWeek 2023 EQL:HER Panel Discussion: From Fertility to Menopause - The Role of Companies in #Women’s #Health Our panel of speakers included Helen O'Neill, Alex Mahon and Dame Vivian Hunt 🎤 Watch the full discussion spr.ly/6017u1SC7 👈
UCL EGA Institute for Women's Health Transform Health Jennifer Hall @DrBolaGrace Catherine Stewart p3-study-ucl "Healthcare wasn’t designed for women, so we made it our mission to change that." Hertility. This innovative healthtech company, applies a precision medicine-based approach to reproductive health, led by UCL EGA Institute for Women's Health lecturer Helen O'Neill. hertilityhealth.com
This is an incredible moment in medical history- the UK Medicines and Healthcare products Regulatory Agency has approved genome editing treatment for #BetaThalassemia & #SickleCellDisease! See my comments in @telegraph and @abc news. abcnews.go.com/amp/Health/wir… #CRISPR Vertex Pharmaceuticals
“The future of life-changing cures resides in CRISPR-based technology,” comments Helen O'Neill UCL EGA Institute for Women's Health UCL Population Health Sciences in The Associated Press after the UK becomes the first country to approve gene therapy for sickle cell disease and beta thalassemia apnews.com/article/sickle…
🗣 Speakers #EBART2024 🔬 Join us for an enlightening presentation by Dr. Helen O'Neill as she kicks off an incredible final session titled: "Frontiers of tomorrow". 📅 Date: April 12th ⏰ Time: 16:30 🔬 Session 8 Frontiers of tomorrow #ART #reproductivescience
🌟Behind the scenes, Dr. Helen O'Neill preparing herself for her talk "Prediction and prevention of infertility through digitalisation". #EBART2024 #ivf
The discussion of female and male infertility remains a taboo subject for many. Helen O'Neill believes that too many young people are sleepwalking into childlessness by not understanding some basic facts about human reproduction. More here: f24.my/AIxi.x
Inspiring day this week at the inaugural Reproduction Symposium at The Francis Crick Institute!🎉Amazing talks on reproductive science from The Francis Crick Institute UCL King's College London Imperial College London Special thanks to @WiebkeArlt MRC Laboratory of Medical Sciences (LMS) for an inspiring keynote on #PCOS and to all speakers & attendees!📸👇
Thanks The Company of Biologists and The Francis Crick Institute for supporting us! Thanks to my co-organizers Helen O'Neill @drbethholder David MacIntyre an absolute pleasure to work together on this🌟
Fundraising for women’s health start-up ‘painful as giving birth’ Helen O'Neill 🙌🏻🙌🏻🙌🏻🙌🏻🙌🏻🙌🏻🙌🏻🙌🏻🙌🏻 thetimes.com/article/699024…
I saw Helen O'Neill at Talent Summit, and after we discussed female reproductive health, how "women's problems" are still taboo and the need to change workplace practices, now! Helen is the founder of Hertility and an educator. She has important things to say...
Helen O'Neill (UCL EGA Institute for Women’s Health) explains the factors behind the rise in secondary infertility. She said: “it’s not just age; it’s compounded by our lifestyle habits”. Read more here ⬇️ #reproductivehealth #ucl #WomensHealth bit.ly/4iJfm7f
From public engagement to policy impact, learn how to communicate your research with clarity and confidence. Join us on Friday, 11 July, at the Institute of Physics in London for our free Standing Up for Science workshop. Apply now! bit.ly/3H7q62b
"Science communication is breaking down your science to be relevant to someone". Our panellist Helen O'Neill raised a strong message on our Standing up for Science workshop today. 👏Huge thanks to all the brilliant panellists today who shared their insights and experiences.